|
|
|
Last Updated: Jun 25th, 2007 - 17:07:26 |
UK smallcap opening - BioProgress ticks up on Middle East move
LONDON (AFX) - BioProgress ticked up 1/4 to 71-1/2 after the company disclosed it will register its pharmaceutical products within the Middle East region. The move follows a better-than-expected market response to the BioProgress technologies at the Arab Health Exhibition in Dubai.
The company is progressing with the approvals process key to getting its non-animal derived (and therefore Halal) products approved.
This, said Bridgewell's Elizabeth Klein, is a large and growing potential market, with significant spending opportunities. The analyst retains her 'buy' recommendation on the stock.
Top of Page
|
|
|
|
|
